Skip to main content

Month: August 2020

Indkaldelse til ekstraordinær generalforsamling i Kapitalforeningen BankInvest, afdeling Small Cap Danske Aktier KL

København Ø, Aug. 19, 2020 (GLOBE NEWSWIRE) —Hermed indkaldes til ekstraordinær generalforsamling i Kapitalforeningen BankInvest, afdeling Small Cap Danske Aktier KL, den 7. september 2020.Dagsordenen kan ses af det vedhæftede dokument, som ligeledes kan downloades fra foreningens hjemmeside www.bankinvest.dk.Venlig hilsenBI Management A/SVedhæftet filIndkaldelse EGF Kap. BI Select, afd. Small Cap DK Akt 2020.09.07

Continue reading

Aura Minerals Reports Significant Drill Intersections at Aranzazu Mine, Zacatecas, Mexico

ROAD TOWN, British Virgin Islands, Aug. 19, 2020 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA) (B3: AURA32) (“Aura” or the “Company”) today provided an update on its exploration program at its Aranzazu Mining Complex located in Zacatecas, Mexico (“Aranzazu”).HighlightsExploration hole M-20-035 intersected 9.99 metres @ 1.70% Cu, 0.93 g/t Au and 17.57 g/t Ag (842.63 – 852.62m) including 3.50 metres @ 2.94% Cu, 2.21 g/t Au and 35.69 g/t Ag (849.12 – 852.62m) extending known inferred mineral resource at Glory Hole zone for further 220 meters downdip. Infill hole M-20-006 intersected 50.02 metres @ 6.46% Cu, 3.68 g/t Au and 95.21 g/t Ag (533.25 – 583.30m) including 34.30 metres @ 8.61% Cu, 4.88 g/t and 127.41 g/t Ag indicating significantly higher grade and thickness zone may be converted from inferred to measured and indicated mineral...

Continue reading

Borregaard ASA: Issuance of Commercial Paper

Borregaard ASA has issued a commercial paper ISIN NO0010891393 of NOK 200,000,000.Start date:                   21 August, 2020Maturity:                     21 February, 2021Coupon:                      0,71 %Organised by:              DNB MarketsSarpsborg, 19 August 2020Contact:CFO, Per Bjarne Lyngstad, mobile +47 952 44 515This information is subject to the disclosure requirements pursuant to Section 5 -12 of the Norwegian Securities Trading Act.  

Continue reading

MediPharm Labs Australia Expands Revenue Opportunity On Expanded GMP Licence

BARRIE, Ontario, Aug. 19, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced that its Australian operation – MediPharm Labs Australia Pty. Ltd. (“MediPharm Labs Australia”) – has received an important enabling amendment to its Good Manufacturing Practice (“GMP”) Certification and Licence to Manufacture Therapeutic Goods.The licence expansion, granted under Section 40B of the Australian Therapeutic Goods Act 1989 by the Therapeutic Goods Administration of the Australian Government’s Department of Health, provides MediPharm Labs with the ability to manufacture Active Pharmaceutical Ingredient (“API”) derived from cannabis...

Continue reading

North Media to pay dividend of DKK 4 per share

Announcement no. 20-202019 August 2020North Media continues to face an increased level of uncertainty from developments in and the consequences of the COVID-19 situation. However, the uncertainty is believed to be less severe now than it was on 18 March 2020 when it was decided as per announcement 12-2020 to suspend the recommendation for the payment of an ordinary dividend for the 2019 financial year.As a result, the Board of Directors resolved today to pay out the dividend of DKK 4.00 per share originally proposed. The total dividend to be distributed amounts to DKK 80.2 million, for a pay-out of DKK 71.8 million exclusive of the holding of treasury shares.The distribution is made as an extraordinary dividend on the basis of an interim balance sheet dated 30 June 2020 with an unqualified review report and no emphasis of matter by PricewaterhouseCoopers...

Continue reading

North Media udbetaler udbytte på 4 kr. pr. aktie

Selskabsmeddelelse nr. 20-202019. august 2020For North Media er der fortsat forhøjet usikkerhed forbundet med udviklingen i og konsekvenserne af COVID-19. Usikkerhederne vurderes imidlertid nu mindre end de var den 18. marts 2020, da det jf. selskabsmeddelelse nr. 12-2020 blev besluttet at suspendere indstillingen om udbetaling af et ordinært udbytte for regnskabsåret 2019.Derfor har bestyrelsen i dag besluttet at gennemføre udbetalingen af det oprindeligt foreslåede udbytte på 4,00 kr. pr. aktie. Samlet udloddes således 80,2 mio. kr., svarende til 71,8 mio. kr. eksklusive beholdningen af egne aktier.Udbyttet udbetales som et ekstraordinært udbytte på baggrund af en mellembalance pr. 30. juni 2020 med reviewerklæring uden forbehold og supplerende oplysninger fra PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.Udlodningen...

Continue reading

Regenerative Medicine Market to Grow at a CAGR of 26.1% to Reach USD 151,949.5 Billion by 2026 | Global Market Size, Trends, Growth, Analysis, Forecast Report [2019-2026]

Pune, Aug. 19, 2020 (GLOBE NEWSWIRE) — The regenerative medicine market size is expected to reach USD 151,949.5 billion by 2026, exhibiting a CAGR of 26.1% during the forecast period.The growing R&D investment by key players for the development of innovative regenerative therapies can be a vital factor enabling the growth of the market during the forecast period, states Fortune Business Insights in a report, titled “Regenerative Medicine Market Size, Share and Industry Analysis By Product (Cell Therapy, Gene Therapy, Tissue Engineering, Platelet Rich Plasma), By Application (Orthopaedics, Wound Care, Oncology), By Distribution Channel (Hospitals, Clinics) & Regional Forecast, 2019 – 2026” the market size stood at USD 23,841.5 Million in 2018. The growing organ transplantation surgeries will spur opportunities for the market...

Continue reading

GTT Receives NYSE Notice Regarding Delayed Form 10-Q Filing

MCLEAN, Va., Aug. 19, 2020 (GLOBE NEWSWIRE) — GTT Communications, Inc. (NYSE: GTT) (the “Company”), a leading global cloud networking provider to multinational clients, today announced that it received a notice from the New York Stock Exchange (the “NYSE”) indicating that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual as a result of its failure to timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2020 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”). The notice has no immediate effect on the listing of the Company’s stock on the NYSE.The NYSE informed the Company that, under the NYSE’s rules, the Company can regain compliance with the NYSE’s continued listing requirements by filing the Form 10-Q with the SEC at any time prior to February...

Continue reading

PolyPid Ltd. Provides Corporate Update and Reports Second Quarter 2020 Financial Results

Initiated Phase 3 SHIELD I Trial for D-PLEX100 in Abdominal Surgery and Received Fast Track Designation for D-PLEX100 from FDAPresented Positive Phase 2 Results of D-PLEX100 for Prevention of Surgical Site Infections in Abdominal Surgery at ASCRS MeetingCompleted Initial Public Offering in U.S., Raising Net Proceeds of $62.8 MillionConference Call scheduled for Wednesday, August 19 at 8:30 AM Eastern TimePETAH TIKVA, Israel, Aug. 19, 2020 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD), a Phase 3 clinical-stage biopharmaceutical company focused on developing targeted, locally administered and prolonged-release therapeutics using its proprietary PLEX technology, today provided a corporate update and reported financial results for the three and six months ended June 30, 2020.Recent Corporate Highlights:Enrolled and randomized the first...

Continue reading

QIWI Announces Second Quarter 2020 Financial Results

Second Quarter Total Net Revenue Increases 23% to RUB 6,839 Million and Adjusted Net Profit Increases 40% to RUB 2,756 Million or RUB 44.19 per diluted shareQIWI upgrades 2020 GuidanceBoard of Directors Approves Dividends of 33 cents per shareNICOSIA, Cyprus, Aug. 19, 2020 (GLOBE NEWSWIRE) — QIWI plc (NASDAQ: QIWI) (MOEX: QIWI) (“QIWI” or the “Company”) today announced results for the second quarter ended June 30, 2020.Second Quarter 2020 Operating and Financial Highlights

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.